P3 Health Partners Inc. (PIII)

P3 Health Partners is an operator of primary care physician practices across multiple states, focused on delivering coordinated, value-based care to patients who have historically been underserved by traditional healthcare networks. The company manages hundreds of physicians and tens of thousands of patient relationships, contracting with health insurers and health systems to provide primary care while shouldering the financial responsibility for patient outcomes. Its business model inverts the traditional fee-for-service incentive: instead of earning per visit or procedure, P3 captures value by keeping patients healthy and out of expensive emergency departments and hospitals.

The shift from volume to value

For decades, American primary care has been built on a simple but perverse incentive: physicians are paid per visit, per test, per procedure — more care generates more revenue, regardless of whether the patient gets better. That arrangement has led to fragmentation, over-testing, unnecessary referrals, and enormous waste. P3 was founded on a different premise: that physicians and care teams, given the right tools and financial incentives, will coordinate care more tightly, avoid duplicative testing, catch complications early, and keep patients out of the hospital.

This is not a new idea — accountable care organizations and capitated payment models have existed in American healthcare for decades — but it remains a minority of how care is actually paid for. P3’s wager is that health insurers and health systems will increasingly shift from fee-for-service to value-based contracts, and that operators with scale, technology, and physician leadership can thrive in that transition.

How the practice management model works

P3 acquires or partners with existing physician practices and medical groups, then provides them with infrastructure: electronic health records, data analytics, coding and billing support, administrative staffing, and contracting expertise. In return, P3 takes a percentage of practice revenue and typically manages the financial risk of patient populations on a per-patient-per-month capitated basis or bundled payment arrangements.

The economic logic is straightforward but execution-dependent. If P3 can reduce preventable hospital admissions, emergency room visits, and specialist referrals among its attributed patients while keeping them healthy and satisfied, the capitated or risk-bearing contract is profitable. If it cannot — if patients get sicker or jump ship to competitors — P3 bears the loss. This alignment of incentives is the entire business case.

Revenue comes from two streams: management fees paid by the practices or health systems P3 operates, and the spread between what insurers or employers pay per patient and what P3 actually spends on their care. The latter is higher-margin but volatile and dependent on careful patient care and cost management.

Size, geography, and competitive position

P3 operates practices across a limited number of states, with particular concentration in markets where value-based contracting is more established — parts of Texas, North Carolina, Florida, and a handful of others. The company manages an attributed patient population numbering in the tens of thousands, and employs hundreds of physicians and thousands of clinical and administrative staff.

In a fragmented, thousands-of-competitors market, P3 is small to mid-sized. It competes against large health systems that own their own practices, against other independent practice-management companies, and against traditional fee-for-service practices. Its edge, in theory, is focus on primary care and value-based contracting at scale — large enough to invest in technology and data analytics, small enough to remain nimble and physician-aligned.

Risks and the adoption question

The core risk is whether the market actually moves toward value-based care as quickly or thoroughly as P3’s model assumes. Healthcare purchasing by insurers has shifted modestly toward value-based contracts in recent years, but the majority of primary care is still fee-for-service. If adoption stalls, P3 has less runway.

Within value-based contracts, P3 faces execution risk: poor care quality, high patient churn, medical losses that eat into margins, and difficulty retaining physicians who dislike the operational changes P3 brings. Scaling is also expensive — each market entry requires local relationships, regulatory navigation, and building care teams and systems from scratch or through acquisition.

Medical-loss management is the perpetual pressure — the difference between what a capitated patient is supposed to cost and what that patient actually costs determines profitability. In early years, that difference is often negative as P3 invests in care redesign; long term, it must turn positive and widen.

How to research P3 as an investment

Start with P3’s annual and quarterly SEC filings (SEC CIK 0001832511), which detail attributed patient lives, capitated revenue, medical-loss ratios, and practice acquisition activity. The company’s commentary on which insurers and health systems are shifting to value-based contracting, and the profitability of those contracts, is crucial — listen closely to earnings calls for candor on medical-loss trends.

Watch for growth in attributed lives, trends in cost per patient, and the company’s ability to retain physicians and practices. The profitability of new markets and the trajectory of mature ones reveal whether P3’s model is actually improving care and reducing costs. Also track healthcare policy: any shift in how Medicare pays primary care, or regulatory changes to value-based contracts, will ripple through P3’s business and the entire sector’s adoption curve.